- Home
- EARN vs AMRN Comparison
EARN vs AMRN Comparison
Compare EARN & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EARN
- AMRN
- Stock Information
- Founded
- EARN 2012
- AMRN 1989
- Country
- EARN United States
- AMRN Ireland
- Employees
- EARN N/A
- AMRN N/A
- Industry
- EARN Real Estate Investment Trusts
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- EARN Real Estate
- AMRN Health Care
- Exchange
- EARN Nasdaq
- AMRN Nasdaq
- Market Cap
- EARN 187.6M
- AMRN 189.2M
- IPO Year
- EARN 2013
- AMRN 1993
- Fundamental
- Price
- EARN $6.60
- AMRN $0.55
- Analyst Decision
- EARN Hold
- AMRN Buy
- Analyst Count
- EARN 1
- AMRN 1
- Target Price
- EARN N/A
- AMRN N/A
- AVG Volume (30 Days)
- EARN 639.2K
- AMRN 1.1M
- Earning Date
- EARN 03-05-2025
- AMRN 02-27-2025
- Dividend Yield
- EARN 14.53%
- AMRN N/A
- EPS Growth
- EARN 277.67
- AMRN N/A
- EPS
- EARN 1.02
- AMRN N/A
- Revenue
- EARN N/A
- AMRN $241,021,000.00
- Revenue This Year
- EARN N/A
- AMRN N/A
- Revenue Next Year
- EARN $89.08
- AMRN N/A
- P/E Ratio
- EARN $6.46
- AMRN N/A
- Revenue Growth
- EARN N/A
- AMRN N/A
- 52 Week Low
- EARN $5.54
- AMRN $0.43
- 52 Week High
- EARN $7.26
- AMRN $1.36
- Technical
- Relative Strength Index (RSI)
- EARN 48.80
- AMRN 50.48
- Support Level
- EARN $6.53
- AMRN $0.55
- Resistance Level
- EARN $6.82
- AMRN $0.61
- Average True Range (ATR)
- EARN 0.13
- AMRN 0.04
- MACD
- EARN 0.00
- AMRN -0.00
- Stochastic Oscillator
- EARN 40.26
- AMRN 26.56
About EARN Ellington Residential Mortgage REIT of Beneficial Interest
Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on strong risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.